HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rieuwert Hoppes Selected Research

Melanoma (Melanoma, Malignant)

11/2014Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.
3/2008Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rieuwert Hoppes Research Topics

Disease

2Melanoma (Melanoma, Malignant)
11/2014 - 03/2008
1Human Influenza (Influenza)
01/2016
1Neoplasms (Cancer)
11/2014

Drug/Important Bio-Agent (IBA)

2EpitopesIBA
01/2016 - 11/2014
2VaccinesIBA
01/2016 - 11/2014
2Peptides (Polypeptides)IBA
11/2014 - 03/2008
1HLA-A Antigens (HLA-A)IBA
01/2016
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2016
1Histocompatibility Antigens Class IIBA
11/2014
1LigandsIBA
03/2008
1HLA-A3 Antigen (HLA A3 Antigen)IBA
03/2008